CAF also interfere with drug resistance by inducing and maintaining the stemness of the tumor, promoting increased efflux of chemotherapeutic drugs, and by secreting pro-inflammatory cytokine IL-6 that has been correlated with resistance to paclitaxel [8, 60, 61]. Here, IL6 is linked to neoplasm.